Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy
ICD-10 E09.610 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy.
E09.610 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by the presence of diabetic neuropathic arthropathy. This condition arises when certain medications, such as glucocorticoids or antipsychotics, lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. The neuropathic arthropathy component indicates that the patient experiences joint pain and deformities due to nerve damage associated with diabetes. This can lead to significant morbidity, as patients may develop foot ulcers or other complications due to loss of sensation. Management of this condition requires careful monitoring of blood glucose levels, often measured by HbA1c, and may necessitate insulin therapy or other antidiabetic medications. The complexity of managing drug-induced diabetes lies in identifying the offending agent, adjusting diabetes treatment accordingly, and addressing the complications that arise from neuropathic arthropathy.
Detailed medication history, HbA1c levels, and assessment of neuropathic symptoms.
Patients presenting with new-onset diabetes after starting a new medication.
Endocrinologists must ensure that the drug-induced nature of the diabetes is clearly documented.
Assessment of foot health, presence of ulcers, and neuropathic symptoms.
Patients with diabetic foot ulcers or deformities due to neuropathy.
Podiatrists should document the relationship between neuropathic arthropathy and diabetes management.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any changes in medication.
Endocrinologists should ensure comprehensive documentation of diabetes control.
Medications such as glucocorticoids, certain antipsychotics, and some antihypertensives can induce diabetes by affecting insulin sensitivity or secretion.
